NBIO Projected Dividend Yield
Nascent Biotech Inc ( OTCBB : NBIO )Nascent Biotech is a clinical-stage biopharmaceutical company that develops monoclonal antibodies for the treatment of various forms of cancer. Co. focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and will further develop those drug candidates for commercial use. Co. owns a drug candidate, Pritumumab, which Co. is developing for a group of cancers known as epithelial cancers (which includes lung, breast, colon, brain, and pancreas). Co. is also focused on patients with brain cancer malignancies such as glioblastoma and malignant astrocytoma. 20 YEAR PERFORMANCE RESULTS |
NBIO Dividend History Detail NBIO Dividend News NBIO Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |